Rapid Micro Biosystems (RPID) Competitors $3.54 +0.05 (+1.43%) Closing price 04:00 PM EasternExtended Trading$3.54 0.00 (0.00%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RPID vs. EYPT, ALNT, LAB, CTKB, SENS, AEHR, QSI, MASS, QTRX, and FEIMShould you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Aehr Test Systems (AEHR), Quantum-Si (QSI), 908 Devices (MASS), Quanterix (QTRX), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry. Rapid Micro Biosystems vs. Its Competitors Eyepoint Pharmaceuticals Allient Standard BioTools Cytek Biosciences Senseonics Aehr Test Systems Quantum-Si 908 Devices Quanterix Frequency Electronics Rapid Micro Biosystems (NASDAQ:RPID) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Do analysts rate RPID or EYPT? Rapid Micro Biosystems presently has a consensus price target of $8.00, suggesting a potential upside of 125.99%. Eyepoint Pharmaceuticals has a consensus price target of $25.67, suggesting a potential upside of 165.70%. Given Eyepoint Pharmaceuticals' higher possible upside, analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Rapid Micro Biosystems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rapid Micro Biosystems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Eyepoint Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, RPID or EYPT? Rapid Micro Biosystems has higher earnings, but lower revenue than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRapid Micro Biosystems$28.05M5.53-$46.89M-$1.03-3.44Eyepoint Pharmaceuticals$43.27M15.36-$130.87M-$2.41-4.01 Do institutionals & insiders hold more shares of RPID or EYPT? 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are owned by institutional investors. 30.0% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 4.5% of Eyepoint Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is RPID or EYPT more profitable? Rapid Micro Biosystems has a net margin of -151.22% compared to Eyepoint Pharmaceuticals' net margin of -261.91%. Eyepoint Pharmaceuticals' return on equity of -54.27% beat Rapid Micro Biosystems' return on equity.Company Net Margins Return on Equity Return on Assets Rapid Micro Biosystems-151.22% -56.07% -44.11% Eyepoint Pharmaceuticals -261.91%-54.27%-41.75% Does the media refer more to RPID or EYPT? In the previous week, Eyepoint Pharmaceuticals had 2 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 3 mentions for Eyepoint Pharmaceuticals and 1 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.87 beat Eyepoint Pharmaceuticals' score of 0.63 indicating that Rapid Micro Biosystems is being referred to more favorably in the media. Company Overall Sentiment Rapid Micro Biosystems Very Positive Eyepoint Pharmaceuticals Positive Which has more risk & volatility, RPID or EYPT? Rapid Micro Biosystems has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. SummaryEyepoint Pharmaceuticals beats Rapid Micro Biosystems on 9 of the 17 factors compared between the two stocks. Get Rapid Micro Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPID vs. The Competition Export to ExcelMetricRapid Micro BiosystemsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$155.16M$6.85B$5.49B$8.93BDividend YieldN/A1.04%5.38%4.12%P/E Ratio-3.4426.5526.2019.89Price / Sales5.5396.47415.50166.23Price / CashN/A21.0536.4957.06Price / Book2.024.748.055.39Net Income-$46.89M$173.18M$3.15B$248.50M7 Day Performance3.21%1.43%1.92%2.96%1 Month Performance2.61%0.25%4.90%6.02%1 Year Performance453.13%29.26%35.95%20.44% Rapid Micro Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPIDRapid Micro Biosystems2.1891 of 5 stars$3.54+1.4%$8.00+126.0%+413.2%$155.16M$28.05M-3.44200Positive NewsEYPTEyepoint Pharmaceuticals2.4211 of 5 stars$8.28-1.7%$25.67+210.0%+14.9%$579.39M$43.27M-3.44120ALNTAllient2.444 of 5 stars$34.61+2.6%$31.00-10.4%+50.5%$570.84M$529.97M58.662,525News CoverageLABStandard BioTools3.5 of 5 stars$1.23+17.1%$2.50+103.3%-25.4%$398.81M$174.43M-3.51620Positive NewsHigh Trading VolumeCTKBCytek Biosciences3.1575 of 5 stars$3.12+5.8%$5.60+79.5%-38.0%$373.64M$200.45M-34.66500News CoverageHigh Trading VolumeSENSSenseonics1.5288 of 5 stars$0.50-2.9%$1.55+212.3%+20.2%$334.24M$23.68M-3.8290AEHRAehr Test Systems4.033 of 5 stars$11.25+0.9%$25.00+122.2%+27.1%$331.95M$66.22M14.4290News CoverageGap UpQSIQuantum-Si2.43 of 5 stars$1.65-4.6%$3.48+110.6%+103.3%$317.45M$3.06M-2.43150Positive NewsMASS908 Devices1.6802 of 5 stars$6.64-9.5%$5.33-19.7%+35.8%$263.22M$63.99M-12.3060QTRXQuanterix2.8341 of 5 stars$6.30+2.9%$15.60+147.6%-47.2%$237.64M$137.42M-4.85460Positive NewsFEIMFrequency Electronics2.5063 of 5 stars$23.24+9.5%N/A+129.8%$205.34M$55.27M9.64200High Trading Volume Related Companies and Tools Related Companies Eyepoint Pharmaceuticals Alternatives Allient Alternatives Standard BioTools Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Aehr Test Systems Alternatives Quantum-Si Alternatives 908 Devices Alternatives Quanterix Alternatives Frequency Electronics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RPID) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapid Micro Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapid Micro Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPID Stock Alerts